Drug Interactions Expert Witnesses

This qualified expert has been involved in the field of medical technologies for over forty years and is experienced with matters concerning FDA compliance on which he has authored several articles and papers and given talks on FDA compliance worldwide. He is also the vice president of a private medical technologies firm, making him intimately qualified to comment on the case at hand.

This highly-qualified expert has 45 years of experience in the field of security and risk management. His areas of expertise include premises liability, nightclub security, security guards, apartment properties, retail loss prevention, negligent hiring/retention and cargo losses due to inadequate security. He earned his BA in sociology with an emphasis in criminology from Louisiana State University. This expert is active in his field as a member of the American Society for Industrial Security, as an author of several published security articles, and a speaker at various security conferences. He began his career with Southern Research Company, serving as a security guard supervisor and as part of the investigations division working on theft and narcotics investigation. He then went on to serve as a patrol officer with the Dallas Police Department and the single unit and area loss prevention manager for Sears. For 12 years, he worked with Eckerd Corporation, serving first as a regional loss prevention manager before becoming the director of loss prevention operations. For nearly 20 years, this expert has served as the president of his risk analysis and security management consulting firm in Texas.

This expert isProfessor and Head of the Department of Health Outcomes Research and Policy at a major university school of pharmacy. He holds a bachelors degree in pharmacy from the University of Wisconsin, and a PhD in Social, Administrative, and Clinical Pharmacy from the University of Minnesota. Prior to joining Auburn University he was Associate Professor of Pharmaceutical Outcomes and Policy in the Eshelman School of Pharmacy at the University of North Carolina. This expert’s research focuses population-level assessment of the benefits and risks of drug treatments. His work has been funded by numerous organizations, including the National Institutes of Health, the Agency for Healthcare Research and Quality, the Foundation for the National Institutes of Health, the National Pharmaceutical Council, and the U.S. Food and Drug Administration. He has worked extensively in the area of comparative effectiveness research and drug safety, and teaches classes related to this work.

This expert has over 30-years of experience in law enforcement, primarily with the Drug Enforcement Administration. He has written three criminal justice textbooks. He currently serves as a Criminal Justice consultant and expert witness with extensive experience in litigation support.

This expert has over 30 years of experience in law enforcement with 20 of those years in the Drug Enforcement Administration. At the DEA, he worked in various positions including Resident Agent in Charge and Inspector. He currently owns a consulting & investigative services firm and works as a Private Investigator specializing in Consulting and Private and Executive Securities.

This board-certified and fellowship-trained expert has over 40 years of experience working as a clinician and researcher of post-traumatic stress disorder. Listed in "The Best Doctors" in America, he is a Distinguished Lifetime Fellow of the American Psychiatric Association and the past president of the International Society of Traumatic Stress Studies. He has over 300 publications including 27 books and monographs. He currently serves as Professor of Psychiatry and Professor of Pharmacology and Toxicology at a major university medical center. He also serves as Senior Advisor at the Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder

This highly qualified Professor of Pharmaceutical Sciences received a bachelors in Pharmacy and a PharmD in Clinical Pharmacy. He is a member of numerous highly regarded professional organizations including the American Association of Pharmaceutical Scientists and the American College of Clinical Pharmacology. He is an innovator with 10 patents registered in his name. He is widely published in Pharmaceutical literature with over 350 articles. In addition to his academic role he currently serves as CEO of three Pharmaceutical companies.

This fellowship-trained doctor received his medical doctorate from the University of Massachusetts School of Medicine. He completed a fellowship in Clinical Pediatric Hematology-Oncology at the prestigious University of Chicago Medical center. He is currently an assistant professor in the department of pediatrics hematology/oncology at a, where he frequently lectures on topics such as vascular abnormalities of the newborn.

This highly qualified expert is a nationally renown authority in toxicology. He received his Ph.D. in pharmacology from the University of Kansas Medical Center. He has served as Toxicology Program Director in the Department of Environmental Health at the University of Washington, then as Associate Chairman of the Department, as Associate Dean for Research in the School of Public Health, and Associate Vice Provost for Research. He is currently Dean and Vice Provost of the Graduate School at the University of Washington. This expert continues his academic appointment as Professor Environmental and Occupational Health Sciences, and Public Health Genetics. He has served as the founding director of the Center for Ecogenetics & Environmental Health, an NIEHS Core Center of Excellence. Nationally, he has served on the Board of Directors and as Treasurer of the American Board of Toxicology, and as President of the Society of Toxicology. He has also served on the Board of Environmental Studies and Toxicology, National Academy of Sciences /National Resource Council, as a member of the Board of Directors and Vice-President of the Toxicology Education Foundation, and on the Board of Trustees of the Academy of Toxicological Sciences. He is an Elected Fellow of the American Association for the Advancement of Science and the Academy of Toxicological Sciences. This expert was elected to the Institute of Medicine of the National Academy of Sciences, and to the Washington State Academy of Sciences. He has published over 150 scientific articles and book chapters in the field of toxicology and risk assessment. He is the sole author of a widely used Law Review article titled on scientific judgment and toxic torts.

This expert began his career as a medical consultant to the emergency room drug treatment and referral program. He’s been practicing for over 40 years and focuses on internal medicine, consulting in clinical pharmacology, and quality assurance medicine. He is currently involved in many aspects of pharmacology, and holds many positions on boards and committees related to drug abuse, prevention, and treatment. He has been a special government employee consultant for the US Department of Health and Human Services, Public Health Service Food and Drug Administration, and Center for Drug Evaluation. He has numerous patents, trademarks, fellowships, grants, and publication and presentations.

This highly qualified Professor of Pharmacology received a bachelor's degree from the University of Illinois and went on to receive a doctorate in Pharmacy from the University of Michigan. He is board certified in Clinical Pharmacology and Nutrition. He is a Fellow of both the American College of Clinical Pharmacology and the American College of Nutrition. he has won many awards throughout his career including the American Society of Pharmacy Law honor for legal writing. He has published over 300 journal articles and book chapters and currently serves as a reviewingeditor of the American Journal of Therapeutics. He is frequently invited to lecture as a guest speaker both nationally and internationally. This expert is a former assistant director of pharmacy at Cook County Hospital, and is currently an associate professor of pharmacology at a major medical college.

This highly qualified Associate Professor earned a masters in Public Health in Epidemiology from the highly regarded Bloomberg School of Public Health. He is board certified in Internal Medicine. He has won many honors throughput his career including the Bruce Squires Award for the Best Research Paper. He is a member of numerous professional societies including the International Society of Pharmacoepidemiology. He serves as a reviewer for more than 50 peer-reviewed medical journals and has published 107 peer-reviewed journal articles. His expertise are highly sought after and he is frequently invited to lecture as a guest speaker both nationally and internationally. He is currently clinically active at a major university affiliated hospital in addition to his academic position.

This expert is a pharmacist and a pharmacologist and a former professor at Yale University and Georgetown University. He is also a former FDA Medical Officer/Senior Medical Analyst, who is an expert in the areas of drug Safety, drug development, regulatory affairs and FDA policy. He as also served as an advisor on the 2016 Ted Cruz presidential campaign, and has also been invited to testify in front of the U.S. Senate as a healthcare policy expert, FDA expert and Pharmacology expert. He has authored or co-authored over 50 publications, papers, articles, reviews, clinical protocols and reports in many related areas including FDA law, drug pricing, healthcare policy, healthcare insurance, drug development and drug patent law.

This highly qualified expert has years of experience in the field of neuropharmacology. He received his PhD degree from the University of California, Santa Barbara, and completed his fellowship training at Harvard University. He is a member of various professional associations, including the American Society of Pharmacology and Experimental Therapeutics and the American Chemical Society. He has published 250+ peer reviewed journal articles and has 51+ US issued patents that focus particularly on neurological studies. He also serves as the editor-in-chief for ACS Chemical Neuroscience, lectures both nationally and internationally and has received multiple honors for his outstanding work, including the John J. Abel award in pharmacology. He is the former co-director of the Synthesis Facility at the Vanderbilt Institute of Chemical Biology and the former senior organic chemist at Eli Lilly & Co. Currently, he is a professor of pharmacology and chemistry at a major university, where he is also the director of medicinal chemistry and DMPK at the Center for Neuroscience Drug Discovery. Additionally, he is the director of drug discovery at a major science institute in Tennessee.

This highly qualified expert earned his Bachelor's degree in Chemistry from the University of California Riverside and his PhD in Comparative Pharmacology and Toxicology from the University of California San Francisco. A member of numerous pharmaceutical societies, he is extremely well published, having authored 120+ peer-reviewed papers and 10 books. He previously served as an Assistant Professor of pharmacology at Washington State University and the University of Southern California. This expert currently serves as an Associate Professor at a top university medical center in southern California.

This qualified expert of Addiction Psychiatry completed his undergrad and MD in Canada at the McGill University. He completed his post-doc Residency and Fellowship in Psychiatry and Pharmacology in Canada at the University of Toronto. He is Board Certified in the US in Psychiatry & Neurology and in Addiction Psychiatry. He is a member of multiple Addiction Psychiatry Medical Associations and has published 200+ Publications on Addiction Psychiatry Research. He is currently a Professor of Psychiatry at a Top Medical University, the Director of a Top University's Addiction Center, and is the Chief Psychiatrist and Associate Medical Director at a Top University Hospital.

This expert's research career has been focused in the area of drug safety. As a clinical epidemiologist and pharmacologist, he uses large administrative databases in Canada and the United States as the main data source for his research. In the last ten years he has made significant contributions to this area quantifying rare drug adverse events with popular prescription drugs. His research has been used by the FDA, Health Canada and European Medicines Agency

This highly qualified expert has been conducting academic studies in toxicology for 30+ years. He completed his postdoctoral and fellowship training at Rochester University. He is a fellow at the American Association for the Advancement of the Sciences and a member of numerous professional associations, including the Academy of Toxicological Sciences, where he serves in the board of directors. He is also the past president of the International Neurotoxicology Association. He has authored approximately 300 peer-reviewed manuscripts and chapters in the area of neurotoxicology and serves on the editorial board of several journals. He is the former director of clinical pharmacology and toxicology at Vanderbilt and the former director of the NIEHS Molecular Toxicology Center. Currently, he is a professor and chair of molecular pharmacology at a major university in New York.

This highly qualified expert has years of experience in using animal models to study diabetes. He received his PhD degree from Ohio State University and completed his fellowship training in physiology and biophysics at the University of Illinois. He has published 98+ peer-reviewed journal articles and serves as a reviewer for 26+ renowned medical journals. He has been listed in "Who's Who in America" for science and engineering and lectures nationwide. Currently, he is a professor of pharmaceutical science and research and the director of pharmacology and toxicology at a major university. He is also the director of the Center for Diagnostic Nanosystems and the associate director of the Cell Differentiation and Development Center at the same institution. Additionally, he is the biological sciences laboratory supervisor at another major university.

This expert is board certified psychiatrist and addiction specialist, and also is certified by the American Board of Disability Analysts. He is an expert in handling capital, personal injury, loss mitigation, malpractice and negligence cases that involve the use of abused substances (especially, opiates, alcohol, hallucinogens, and stimulants), prescribed pharmacological agents, and in the general field of psychiatric and brain disease. This expert also is a leading neuroscientist and neuropsychopharmacologist. He can provide expert testimony on the effects of different brain states and function, in both health and disease, and their potential association with with legal culpability and liability. He currently serves as the Chairman of the Department of Psychiatry at a leading university in the USA, and has over 12 years experience as Chairman in Psychiatry Departments in the USA. His research focus is in the neuropsychopharmacology of addiction, addiction and pain, pain treatment, impact of genetics on human behavior, the basic, molecular, and the brain imaging sciences related to the functioning of the brain in health, disease and addiction. In recognition of his academic, scholarly and professional achievement, he is a Fellow of the Collegium Internationale Neuro-psychopharmacologicum and a Distinguished Fellow of the American Psychiatric Association. He is the recipient of numerous professional and scientific awards, including the Jack Mendelson Award at the NIH, which is awarded to individuals who have made distinguished contributions to our understanding of the science of addiction. He has an h-index of 46, and 11829 citations of his published work.